Ovid Therapeutics Inc.

OVID · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$12-$5-$10-$9
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$0
Change in WC-$2-$1-$1-$1
Other Non-Cash$1-$0-$0-$0
Operating Cash Flow-$13-$5-$10-$10
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$5-$5-$5-$17
Inv. Sales/Matur.$10$17$10$38
Other Inv. Act.$0$0$0$0
Investing Cash Flow$5$12$5$21
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$8$7-$5$11
Supplemental Information
Beg. Cash$28$23$28$15
End Cash$21$30$23$26
Free Cash Flow-$13-$5-$10-$10